GLPG3970 film-coated tablet

DRUG2 trials

Sponsors

Galapagos NV

Conditions

HealthySystemic Lupus Erythematosus

Phase 1

A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus

TerminatedNCT04700267

Galapagos NVSystemic Lupus Erythematosus

Start: 2020-12-28End: 2021-10-06Updated: 2021-10-21

Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970

CompletedNCT04907149

Galapagos NVHealthy

Start: 2021-06-07End: 2021-07-12Updated: 2021-07-23